Table of Contents
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Drivers
4.2 Restraints
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Supply Chain Analysis
6. Europe, Middle East & Africa Cardiac Valve Market, by Type
6.1 Transcatheter Heart Valve
6.2 Tissue Heart Valve
6.3 Mechanical Heart Valve
6.4 Others
7. Europe, Middle East & Africa Cardiac Valve Market, By Disease
7.1 Aortic Valve Replacement
7.2 Heart Valve Disease
7.3 Mitral Valve Stenosis
7.4 Others
8. Europe, Middle East & Africa Cardiac Valve Market, by Treatment
8.1 Valve Replacement
8.2 Valve Repair
8.3 Other
9. Europe, Middle East & Africa Cardiac Valve Market, by End Users
9.1 Cardiac Research Institute
9.2 Hospital & Clinics
9.3 Other
10. Europe, Middle East & Africa Cardiac Valve Market, by Region
10.1 Introduction
10.2 Europe
10.2.1 Western Europe
10.2.1.1 Germany
10.2.1.2 UK
10.2.1.3 France
10.2.1.4 Italy
10.2.1.5 Spain
10.2.1.6 Rest of Western Europe
10.2.2 Eastern Europe
10.3 The Middle East & Africa
10.3.1 United Arab Emirates
10.3.2 Saudi Arabia
10.3.3 Oman
10.3.4 Kuwait
10.3.5 Qatar
10.3.6 Rest of Middle East & Africa
11 Competitive Landscape
11.1 Introduction
11.2 Market share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profile
12.1 Medtronic
12.1.1 Overview
12.1.2 Product/Business Segment Overview
12.1.3 Financial Updates
12.1.4 Key Developments
12.2 Edwards Lifesciences Corporation
12.2.1 Overview
12.2.2 Product/Business Segment Overview
12.2.3 Financial Updates
12.2.4 Key Developments
12.3 Boston Scientific Corporation
12.3.1 Overview
12.3.2 Product/Business Segment Overview
12.3.3 Financial Updates
12.3.4 Key Development
12.4 LivaNova PLC
12.4.1 Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Updates
12.4.4 Key Development
12.5 Symetis SA
12.5.1 Overview
12.5.2 Product/Business Segment Overview
12.5.3 Financial Updates
12.5.4 Key Developments
12.6 Colibri Heart Valve, LLC
12.6.1 Overview
12.6.2 Product/Business Segment Overview
12.6.3 Financial Updates
12.6.4 Key Developments
12.7 Jenavalve Technology, Inc.
12.7.1 Overview
12.7.2 Product/Business Segment Overview
12.7.3 Financial Updates
12.7.4 Key Developments
12.8 CryoLife, Inc.
12.8.1 Overview
12.8.2 Product/Business Segment Overview
12.8.3 Financial Updates
12.8.4 Key Developments
12.9 TTK HealthCare
12.9.1 Overview
12.9.2 Product/Business Segment Overview
12.9.3 Financial Updates
12.9.4 Key Developments
12.10 Others
13 Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Cardiac Valve Industry
14 Appendix